drugset / Trial / NCT01004354

Vitamin D Supplementation in Psychiatric Illnesses

NCT01004354 ↗

NaSingle-groupOpen-labelTreatment

Summary

Children and adolescents with psychiatric illnesses who are treated with medications called second generation antipsychotic agents (SGA) often gain excessive weight during their treatment with these medications. This weight gain may result in the development of features of the metabolic syndrome or frank diabetes mellitus. There is no consensus on the best way to prevent these complications. The investigators' hypothesis is that daily vitamin D supplementation in these patients will result in decreased levels of the markers of metabolic syndrome with associated reduction in waist circumference.

Timeline

Start
2009-06
Primary completion
2010-06
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Ergocalciferols Unknown 2000 iu Oral